Successful monotherapy with autologous formalin‐fixed tumor vaccine for a Stage IV uterine cancer patient who rejected rational chemotherapy and immune checkpoint inhibitor treatment

KEY CLINICAL MESSAGE: To overcome patient‐initiated treatment refusal because of fear of experiencing severe negative adverse events, mild immunotherapy using a cancer vaccine such as the autologous formalin‐fixed tumor vaccine should be considered. ABSTRACT: A patient who refused chemotherapy and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Katsuhiko, Ohno, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250682/
https://www.ncbi.nlm.nih.gov/pubmed/37305860
http://dx.doi.org/10.1002/ccr3.7513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250682/
https://www.ncbi.nlm.nih.gov/pubmed/37305860
http://dx.doi.org/10.1002/ccr3.7513

Ejemplares similares